Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$87.2 - $114.05 $163,325 - $213,615
1,873 New
1,873 $201,000
Q1 2022

May 10, 2022

SELL
$94.19 - $124.49 $154,000 - $203,541
-1,635 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$109.17 - $142.35 $178,492 - $232,742
1,635 New
1,635 $218,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Trust Asset Management LLC Portfolio

Follow Trust Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trust Asset Management LLC with notifications on news.